Why Is French Pharma Giant Sanofi Stock Trading Higher On Thursday?
Sanofi's rilzabrutinib receives FDA orphan drug designation for two rare diseases. Clinical studies show meaningful response ...
FDA approves Qfitlia to cut bleeding episodes in patients with hemophilia
The U.S. Food and Drug Administration has approved Sanofi's Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce ...
H.C. Wainwright维持Alnylam股票500美元目标价
Investing.com — 周四，H.C. Wainwright重申了对Alnylam Pharmaceuticals (NASDAQ: ALNY )的"买入"评级和500.00美元的目标价，较当前266.83美元的价格有87%的上涨空间。根据 InvestingPro 数据，分析师对该股票保持看涨共识，目标价格范围从206美元到500美元不等。该公司分析师Patrick ...
Bernstein Sticks to Their Buy Rating for Sanofi (SNYNF)
Bernstein analyst Florent Cespedes maintained a Buy rating on Sanofi (SNYNF – Research Report) today and set a price target of €114.00. The ...